Neumora Therapeutics Inc (NMRA)

$0.81 +0.02 (2.54%)
Market Cap 127.78M
Revenue (ttm) 0.00
Net Income (ttm) -243.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 544,800
Avg Vol 923,256
Day's Range N/A - N/A
Shares Out 161.75M
Stochastic %K 79%
Beta 2.73
Analysts Sell
Price Target $5.67

Latest News on NMRA

Neumora Therapeutics, Inc. (NMRA) Q1 2025 Earnings Call Transcript

May 12, 2025, 7:18 PM EDT - 24 days ago

Neumora Therapeutics, Inc. (NMRA) Q1 2025 Earnings Call Transcript

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 4:01 PM EDT - 24 days ago

Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Apr 28, 2025, 7:00 AM EDT - 5 weeks ago

Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

NMRA Deadline: NMRA Investors with Losses in Excess of $100K Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Apr 4, 2025, 4:05 PM EDT - 2 months ago

NMRA Deadline: NMRA Investors with Losses in Excess of $100K Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

NMRA Deadline: NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Mar 30, 2025, 4:00 PM EDT - 2 months ago

NMRA Deadline: NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit - NMRA

Mar 27, 2025, 5:45 AM EDT - 2 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit - NMRA

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

Mar 26, 2025, 2:19 AM EDT - 2 months ago

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 15, 2025, 9:29 AM EDT - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 13, 2025, 10:19 AM EDT - 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit – NMRA

Mar 6, 2025, 12:17 PM EST - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Neumora Therapeutics, Inc. Lawsuit – NMRA

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

Mar 4, 2025, 8:30 AM EST - 3 months ago

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

Neumora Therapeutics, Inc. (NMRA) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 11:37 AM EST - 3 months ago

Neumora Therapeutics, Inc. (NMRA) Q4 2024 Earnings Call Transcript

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 3, 2025, 7:00 AM EST - 3 months ago

Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Investors in Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

Feb 27, 2025, 5:45 AM EST - 3 months ago

Investors in Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

Robbins LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses

Feb 26, 2025, 8:46 PM EST - 3 months ago

Robbins LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses

Investors in Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights – NMRA

Feb 26, 2025, 1:32 PM EST - 3 months ago

Investors in Neumora Therapeutics, Inc. Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights – NMRA

NMRA Investors are Suing Neumora Therapeutics, Inc.; Contact Robbins LLP for More Information

Feb 20, 2025, 5:41 PM EST - 3 months ago

NMRA Investors are Suing Neumora Therapeutics, Inc.; Contact Robbins LLP for More Information

NMRA REMINDER: Kessler Topaz Meltzer & Check, LLP Urges NMRA Investors with Losses to Contact the Firm

Feb 19, 2025, 10:08 PM EST - 3 months ago

NMRA REMINDER: Kessler Topaz Meltzer & Check, LLP Urges NMRA Investors with Losses to Contact the Firm

Neumora Therapeutics Announces Leadership Transition

Feb 13, 2025, 7:00 AM EST - 4 months ago

Neumora Therapeutics Announces Leadership Transition

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Neumora Therapeutics, Inc. (NMRA)

Feb 7, 2025, 10:42 AM EST - 4 months ago

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Neumora Therapeutics, Inc. (NMRA)